Search Results - "Sánchez‐Barroso, Lara"
-
1
Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy
Published in The oncologist (Dayton, Ohio) (01-08-2019)“…Background Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs, including paclitaxel. There is large interindividual variability in the…”
Get full text
Journal Article -
2
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy
Published in Clinical cancer research (15-01-2015)“…Paclitaxel, a widely used chemotherapeutic drug, can cause peripheral neuropathies leading to dose reductions and treatment suspensions and decreasing the…”
Get full text
Journal Article -
3
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
Published in BMC cancer (19-01-2017)“…Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It…”
Get full text
Journal Article -
4
Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy
Published in Clinical cancer research (01-03-2017)“…Neuropathy is the dose-limiting toxicity of paclitaxel and a major cause for decreased quality of life. Genetic factors have been shown to contribute to…”
Get full text
Journal Article -
5
-
6
Acute Impacts of Different Types of Exercise on Circulating α-Klotho Protein Levels
Published in Frontiers in physiology (01-09-2021)“…Introduction: Elevated plasma α-klotho (αKl) protects against several ageing phenotypes and has been proposed as a biomarker of a good prognosis for different…”
Get full text
Journal Article -
7
Letter: Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel-Letter in CLINICAL CANCER RESEARCH, vol 21, issue 13, pp 3092-3093
Published in Clinical cancer research (2015)Get full text
Journal Article